Enjoy complimentary customisation on priority with our Enterprise License!
According to Technavio’s market research report, the global liver disease treatment market will grow at a CAGR of more than 11% during the forecast period. One of the key factors that will drive market’s growth during the forecast period is the rising prevalence of alcohol-related liver disease. The liver plays a major role in removing toxins and impurities such as alcohol from the blood. The cells of the liver are destroyed each time it processes the alcohol content in the body. Continuous exposure to heavy alcohol can damage the liver making it difficult for the cells to regenerate. This can result in liver cirrhosis and even death in severe cases. According to NIH, an estimated 88,000 people succumb to alcohol-related illnesses every year. It has been observed that the consumption of alcohol is increasing in developing economies such as India. In India, more than one fourth of citizens consume alcohol. The hazardous drinking habits of the population of south Asian countries will increase the prevalence of alcohol related liver problems, boosting the demand for alcohol related liver disease treatments.
The Americas contributed to the maximum market shares during 2016 due to the presence of major players in this region. The market will continue to grow in the region in the forthcoming years due to the increased investment in R&D activities by the governments of various countries. Furthermore, the increasing prevalence of lifestyle disorders such as diabetes and obesity will drive the risk of liver disease in the region, boosting the need for liver disease treatments in the liver transplant market.
The liver disease treatment market is characterized by the presence of leading players. These vendors are increasingly competing against each other based on factors such as aggressive pricing and new indications. Large vendors in the liver transplant market are collaborating with small and mid-sized vendors to develop better drugs. Additionally, they are also focusing on expanding their product portfolio and enhancing their geographical footprints by adopting strategic collaborations.
Key vendors in this market are -
Other prominent vendors in the market include Bristol-Myers Squibb, Johnson and Johnson, Novartis, Salix Pharmaceuticals, and Vertex Pharmaceuticals.
Hepatitis is a major liver disease that can be both viral and non-viral. Anti-viral drugs are highly preferred for the treatment of viral hepatitis as they inhibit the growth of target pathogens. Hepatitis A, B, and C are the most common types of viral infections. Anti-viral drugs are also used to treat HIV, herpes, and influenza. The sales volume of direct-acting antiviral drugs such as Gilead's Harvoni and Sovaldi will increase during the predicted period in the liver transplant market since they have the ability to treat all strains of the hepatitis virus.
The alcohol related liver disease (ARLD) is caused due to the overconsumption of alcohol and is a hepatic manifestation. The symptoms for ARLD include weight loss, loss of appetite, jaundice, drowsiness, swelling in the abdomen and ankles, and the passing of blood in the stool or vomiting blood. These symptoms are visible only when the liver has been severely damaged. ARLD can result in internal bleeding, encephalopathy or build-up of toxins in the brain, and kidney failure, which in turn, will drive the demand for ARLD drugs or liver disease.
Technavio also offers customization on reports based on specific client requirement
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Pipeline landscape
PART 07: Drug class segmentation
PART 08: Market segmentation by disease type
PART 09: Geographical segmentation
PART 10: Decision framework
PART 11: Drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
PART 14: Key vendor analysis
PART 15: Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.